Korea injects new funds to gain stem cell, gene therapy edge
This article was originally published in Clinica
Executive Summary
The South Korean government is to invest a total of KRW340bn ($305.4m) in 2015 to support and nurture stem cell and gene therapy firms, in a bid to gain a stronger position in these sectors